Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1978 Apr;41(4):307–311. doi: 10.1136/jnnp.41.4.307

Metabolism of immunoglobulin A, lymphocyte function, and histocompatibility antigens in patients on anticonvulsants.

R A Shakir, P O Behan, H Dick, D G Lambie
PMCID: PMC493022  PMID: 306420

Abstract

Low serum IgA levels were found in patients taking phenytoin, together with evidence of depressed T cell function. There was no correlation between the dose or the serum level. A correlation was found, however, with HL-A status, patients with a low IgA showing increased frequency of HL-A2. It is suggested that epileptic patients with HL-A2 status are likely to develop IgA deficiency when given phenytoin.

Full text

PDF
307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bankhurst A. D., Warner N. L. Surface immunoglobulins on the thoracic duct lymphocytes of the congenitally athymic (nude) mouse. Aust J Exp Biol Med Sci. 1972 Oct;50(5):661–664. doi: 10.1038/icb.1972.58. [DOI] [PubMed] [Google Scholar]
  2. Behan P. O., Behan W. M., Zacharias F. J., Nicholls J. T. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet. 1976 Nov 6;2(7993):984–987. doi: 10.1016/s0140-6736(76)90831-x. [DOI] [PubMed] [Google Scholar]
  3. Claman H. N., Hartley T. F., Merrill D. Hypogammaglobulinemia, primary and secondary: immunoglobulin levels (gamma-G, gamma-A, gamma-M) in one hundred and twenty-five patients. J Allergy. 1966 Oct;38(4):215–225. doi: 10.1016/0021-8707(66)90055-4. [DOI] [PubMed] [Google Scholar]
  4. Fontana A., Grob P. J., Sauter R., Joller H. IgA deficiency, epilepsy, and hydantoin medication. Lancet. 1976 Jul 31;2(7979):228–231. doi: 10.1016/s0140-6736(76)91028-x. [DOI] [PubMed] [Google Scholar]
  5. Goudie J. H., Burnett D. A gas-chromatographic method for the simultaneous determination of phenobarbitone, primidone and phenytoin in serum using a nitrogen detector. Clin Chim Acta. 1973 Feb 12;43(3):423–429. doi: 10.1016/0009-8981(73)90482-8. [DOI] [PubMed] [Google Scholar]
  6. Grob P. J., Herold G. E. Immunological abnormalities and hydantoins. Br Med J. 1972 Jun 3;2(5813):561–563. doi: 10.1136/bmj.2.5813.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hobbs J. R. Immune imbalance in dysgammaglobulinaemia type IV. Lancet. 1968 Jan 20;1(7534):110–114. doi: 10.1016/s0140-6736(68)92721-9. [DOI] [PubMed] [Google Scholar]
  8. Kruger G. R., Harris D. Is phenytoin carcinogenic? Lancet. 1972 Feb 5;1(7745):323–323. doi: 10.1016/s0140-6736(72)90333-9. [DOI] [PubMed] [Google Scholar]
  9. Norris J. W., Pratt R. F. Folic acid deficiency and epilepsy. Drugs. 1974;8(5):366–385. doi: 10.2165/00003495-197408050-00005. [DOI] [PubMed] [Google Scholar]
  10. Odgers R. J., Wangel A. G. Abnormalities in IgA-containing mononuclear cells in the gastric lesion of pernicious anaemia. Lancet. 1968 Oct 19;2(7573):846–849. doi: 10.1016/s0140-6736(68)91001-5. [DOI] [PubMed] [Google Scholar]
  11. Scheurlen P. G., Schneider W., Pappas A. Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer. Lancet. 1971 Dec 4;2(7736):1265–1265. doi: 10.1016/s0140-6736(71)90586-1. [DOI] [PubMed] [Google Scholar]
  12. Simpson J. A., Behan P. O., Dick H. M. Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type. Ann N Y Acad Sci. 1976;274:382–389. doi: 10.1111/j.1749-6632.1976.tb47699.x. [DOI] [PubMed] [Google Scholar]
  13. Slavin B. N., Fenton G. M., Laundy M., Reynolds E. H. Serum immunoglobulins in epilepsy. J Neurol Sci. 1974 Nov;23(3):353–357. doi: 10.1016/0022-510x(74)90153-1. [DOI] [PubMed] [Google Scholar]
  14. Sorrell T. C., Forbes I. J., Burness F. R., Rischbieth R. H. Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). Lancet. 1971 Dec 4;2(7736):1233–1235. doi: 10.1016/s0140-6736(71)90547-2. [DOI] [PubMed] [Google Scholar]
  15. Sorrell T. C., Forbes I. J. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin Exp Immunol. 1975 May;20(2):273–285. [PMC free article] [PubMed] [Google Scholar]
  16. Thomas D. G., Lannigan C. B., Behan P. O. Letter: Impaired cell-mediated immunity in human brain tumours. Lancet. 1975 Jun 21;1(7921):1389–1390. doi: 10.1016/s0140-6736(75)92308-9. [DOI] [PubMed] [Google Scholar]
  17. Tomasi T. B., Jr Human immunoglobulin A. N Engl J Med. 1968 Dec 12;279(24):1327–1330. doi: 10.1056/NEJM196812122792408. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES